Ethic Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ethic Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$5,899,009
-3.4%
455,874
+3.7%
0.14%
-10.4%
Q1 2024$6,109,081
+17.2%
439,819
+20.4%
0.15%0.0%
Q4 2023$5,213,268
-27.0%
365,331
-20.9%
0.15%
-38.6%
Q3 2023$7,144,775
+12.9%
461,847
+14.6%
0.25%
+6.8%
Q2 2023$6,329,592
+8.0%
402,902
+13.2%
0.24%
-1.3%
Q1 2023$5,863,240
+27.5%
355,779
+20.7%
0.24%
-4.0%
Q4 2022$4,599,007
+154.7%
294,808
+111.7%
0.25%
+101.6%
Q3 2022$1,806,000
-19.0%
139,246
-12.3%
0.12%
-20.6%
Q2 2022$2,230,000
-36.9%
158,863
-35.6%
0.16%
-36.5%
Q1 2022$3,532,000
+85.3%
246,628
+76.3%
0.24%
+66.0%
Q4 2021$1,906,000
+30.0%
139,865
+56.3%
0.15%
-2.0%
Q3 2021$1,466,000
+28.6%
89,481
+32.1%
0.15%
+8.7%
Q2 2021$1,140,000
+9.0%
67,733
+18.2%
0.14%
-25.8%
Q1 2021$1,046,000
+59.9%
57,295
+59.4%
0.19%
+7.5%
Q4 2020$654,000
+2.8%
35,945
+0.9%
0.17%
-28.8%
Q3 2020$636,000
+30.1%
35,630
+30.6%
0.24%
-12.6%
Q2 2020$489,000
+45.1%
27,284
+22.9%
0.28%
-1.1%
Q1 2020$337,000
-6.4%
22,196
+21.7%
0.28%
+6.0%
Q4 2019$360,00018,2390.26%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 9,270,535$188,841,00039.13%
Sachem Head Capital 5,963,600$121,479,0007.38%
NINE MASTS CAPITAL Ltd 1,049,886$21,415,0006.68%
Paulson & Co. 26,489,422$539,590,0005.77%
Blackcrane Capital, LLC 189,549$3,861,0005.16%
Glenview Capital Management 26,112,660$531,915,0004.75%
Exane Asset Management 430,369$8,766,617,0004.26%
Velanne Asset Management Ltd 281,972$5,744,0003.97%
Bluefin Trading, LLC 1,204,702$24,540,0003.55%
Endurant Capital Management LP 437,436$8,911,0003.52%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders